Clearwater Analytics Holdings, Inc.

CWAN

CWAN operates in the prepackaged software industry, providing software solutions as a service.
It is characterized by its emphasis on subscription-based revenue streams and cloud-native platforms designed for scalability and recurring customer value.

$23.39 -0.07 (-0.30%)

Updated: February 27, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy CWAN Today?

Comprehensive Analysis of CWAN

Technical Perspective CWAN shows promising momentum, having significantly outperformed the market over the past three months with notably lower volatility, as indicated by its low beta. Currently trading in the middle-to-upper portion of its annual range, the stock appears neither overbought nor oversold, suggesting potential for further movement in either direction depending on catalyst developments.

Fundamental Assessment The company demonstrates positive top-line growth with improving quarterly revenue, though profitability remains a challenge with negative net income and returns on equity/assets. While liquidity appears adequate with a reasonable debt level, the weak interest coverage ratio raises near-term concerns about financial stability. Operational efficiency needs improvement, particularly in asset utilization and working capital management.

Valuation & Risk Considerations Valuation metrics are challenging to interpret due to negative earnings, making traditional multiples less meaningful; the extremely high EV/EBITDA ratio suggests the market expects substantial future growth. Risk appears moderated by low market volatility and absent short interest, though the history of sharp drawdowns indicates company-specific vulnerabilities that require monitoring.

---

Investment Recommendation

Consider a cautious buy for growth-oriented investors. CWAN's recent technical outperformance with low volatility and sequential revenue growth provides a positive backdrop, though profitability remains elusive. The stock appears reasonably positioned for investors willing to accept near-term financial uncertainty in anticipation of future margin improvement. However, this recommendation carries higher risk given the current negative earnings and should represent only a small, speculative portion of a diversified portfolio.

CTA Banner

CWAN 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on a comprehensive review, here is the 12-month outlook for CWAN:

12-Month Outlook for CWAN

The primary positive catalyst for CWAN is the continuation of its strong quarterly revenue growth, which the market is rewarding as evidenced by its recent technical outperformance; a key milestone would be the company translating this top-line expansion into a credible path toward profitability. The most significant risk remains its lack of earnings and weak interest coverage, which exposes the stock to sharp drawdowns if growth slows or margin improvement is delayed. While analyst targets are not available, the current valuation implies high growth expectations, and a cautious target range would likely be contingent on demonstrating improved operational efficiency, with substantial upside potential only materializing upon achieving sustainable profitability.

Wall Street Consensus

Most Wall Street analysts are optimistic about Clearwater Analytics Holdings, Inc.'s 12-month outlook, with consensus target around $23.39, indicating expected upside potential.

Average Target
$23.39
11 analysts
Implied Upside
+0%
vs. current price
Analyst Count
11
covering this stock
Price Range
$19 - $30
Analyst target range
Buy Buy
1 (9%)
Hold Hold
10 (91%)
Sell Sell
0 (0%)

Bulls vs Bears: CWAN Investment Factors

Overall, CWAN has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Definitive Acquisition Agreement: Firm $8.4 billion buyout offer at a significant premium to prior undisturbed share price.
  • Share Price Premium: $24.55 per share cash offer represents a 47% premium, driving a 34% monthly rebound.
  • Strong Buyer Consortium: Acquisition backed by major private equity firms Permira, Warburg Pincus, and Francisco Partners.
  • Potential for Higher Bids: Go-shop window may attract competing offers, fueling further investor optimism and price speculation.
  • Activist Investor Interest: Activist pressure is seen as a catalyst for boosting shareholder value.
Bearish Bearish
  • Premium Valuation Concerns: A high P/S ratio of 9.6x suggests the stock may be expensive relative to sales.
  • Lack of Organic Growth: Analyst reports indicate that fundamental business growth is currently lacking.
  • Pre-Deal Share Price Weakness: Stock had been trading lower, indicating underlying challenges before the acquisition news.
  • Deal Dependency Risk: Current high valuation is heavily reliant on the successful completion of the acquisition.
Reward Banner

CWAN Technical Analysis

CWAN has demonstrated mixed performance with significant volatility but notable recent outperformance against the broader market. The stock has experienced a substantial maximum drawdown over the past year yet has rebounded strongly in the medium term.

The stock declined marginally over the past month but posted a solid 13.06% gain over three months, significantly outperforming the market by 7.43% during that period. CWAN's low beta of 0.66 indicates this strong relative performance has been achieved with below-average volatility compared to the broader market.

Currently trading at $23.46, CWAN sits approximately 49% above its 52-week low but about 26% below its yearly high, positioning it in the middle-to-upper portion of its annual range. Considering the stock's history of deep drawdowns and its recent advance, it appears to be in a neutral position rather than strongly overbought or oversold.

šŸ“Š Beta
0.66
0.66x market volatility
šŸ“‰ Max Drawdown
-48.9%
Largest decline past year
šŸ“ˆ 52-Week Range
$16-$31
Price range past year
šŸ’¹ Annual Return
-24.8%
Cumulative gain past year
Period CWAN Return S&P 500
1m -3.1% -1.4%
3m +8.4% +4.1%
6m +19.6% +7.5%
1y -24.8% +15.4%
ytd -3.0% +0.4%

CWAN Fundamental Analysis

Revenue & Profitability CWAN showed sequential revenue growth from $205 million to $217 million quarter-over-quarter, indicating positive top-line momentum. However, profitability remains challenged with a negative net income ratio of -5.4% in Q4, though this modestly improved from -5.0% in Q3. The company maintains a strong gross profit margin of 67%, but high operating expenses continue to pressure bottom-line results.

Financial Health The company maintains adequate liquidity with a current ratio of 1.83 and quick ratio matching, though the cash ratio of 0.57 suggests moderate cash coverage. While the debt-to-equity ratio of 0.44 indicates reasonable leverage, the interest coverage ratio of 0.71 shows insufficient operating income to comfortably service interest obligations, presenting near-term liquidity concerns.

Operational Efficiency CWAN demonstrates weak operational metrics with a negative return on equity of -0.58% and near-zero return on assets of -0.39%. The asset turnover ratio of 0.07 indicates inefficient utilization of assets to generate revenue. However, the cash conversion cycle of 66 days, while extended, is primarily driven by high days sales outstanding rather than inventory management issues.

Quarterly Revenue
$0.2B
2025-12
Revenue YoY Growth
+72.0%
YoY Comparison
Gross Margin
67.2%
Latest Quarter
Free Cash Flow
$-0.8B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is CWAN Overvalued?

Valuation Level: CWAN's valuation metrics present significant challenges for traditional analysis, as both trailing and forward PE ratios are deeply negative due to ongoing losses. The extremely high EV/EBITDA ratio of 192.6 further confirms substantial valuation concerns, indicating the market is pricing the stock at nearly 193 times its current earnings before interest, taxes, depreciation, and amortization, which is unsustainable for most companies.

Peer Comparison: Without industry average data available for comparison, CWAN's PB ratio of 3.4 cannot be contextualized against sector norms. However, the consistently negative earnings metrics and exceptionally high EV/EBITDA suggest the company faces fundamental profitability challenges that would likely place it at a disadvantage compared to profitable peers in whatever sector it operates.

PS
9.4x
Price-to-Sales Ratio
vs. Historical
Mid-Range
5-Year PE Range -5199Ɨ-10108Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/EBITDA
192.6x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility risk appears moderated despite a significant recent drawdown. The beta of 0.66 suggests the stock is historically about one-third less volatile than the broader market. However, the substantial one-year maximum drawdown of -48.91% indicates it has experienced sharp, specific price declines that are not fully captured by its low beta, pointing to potential idiosyncratic risk.

Other risks are limited by favorable liquidity and market sentiment indicators. The noted absence of short interest implies a lack of significant negative speculative pressure on the stock. This, combined with typical liquidity for a listed company, reduces the immediate risks associated with a short squeeze or difficulty exiting a position.

FAQs

Is CWAN a good stock to buy?

Neutral. CWAN's strong sell-side consensus and lack of organic growth are significant fundamental headwinds; however, the stock is currently a speculative play on the pending $8.4 billion acquisition. The cash offer at a premium provides a potential price floor, but the risk of the deal falling through makes it highly volatile. This is suitable only for speculative investors comfortable with event-driven, binary-outcome risk.

Is CWAN stock overvalued or undervalued?

Based on the provided metrics, CWAN appears significantly overvalued. Its deeply negative P/E and P/E Growth (PEG) ratios, coupled with an exceptionally high PS ratio of 9.44 and EV/EBITDA of 192.6, indicate the market is pricing in extraordinary future growth that is not supported by current fundamentals. The primary reason for this concerning valuation is the combination of persistent unprofitability (negative net income) and weak operational efficiency (negative ROE/ROA), suggesting the stock price is disconnected from the company's current earnings power and financial health.

What are the main risks of holding CWAN?

Based on the provided information, here are the key risks of holding CWAN stock, ordered by importance:

1. Financial Risk: The company's interest coverage ratio of 0.71 indicates that its operating income is insufficient to cover its interest payments, creating a near-term liquidity and solvency concern. 2. Business/Profitability Risk: CWAN is currently unprofitable with a negative net income margin, driven by high operating expenses that its strong gross margin cannot overcome. 3. Idiosyncratic/Volatility Risk: Despite a low beta, the stock has experienced a severe maximum drawdown of -48.91%, indicating it is susceptible to sharp, company-specific price declines not explained by general market movements.

What is the price forecast for CWAN in 2026?

Based on current fundamentals and growth trajectory, my forecast for CWAN through 2026 is as follows:

I project a base case target range of $27-$32 and a bull case of $38-$45 by 2026, contingent primarily on the company translating its impressive revenue growth into sustainable profitability. Key growth drivers include maintaining its strong >65% gross margins while achieving operating leverage, successful expansion of its cybersecurity platform offerings, and improved cash flow generation to address near-term liquidity concerns. My main assumptions are that quarterly revenue growth continues at 5-7% and that management executes on cost controls to reach breakeven by late 2025. This forecast carries significant uncertainty given CWAN's current lack of earnings and weak interest coverage, meaning any growth slowdown or profitability delay could substantially impair valuation.